Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Corneal avascularity is due to soluble VEGF receptor-1.

Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J.

Nature. 2006 Oct 26;443(7114):993-7. Epub 2006 Oct 18.

2.

Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.

Ambati BK, Patterson E, Jani P, Jenkins C, Higgins E, Singh N, Suthar T, Vira N, Smith K, Caldwell R.

Br J Ophthalmol. 2007 Apr;91(4):505-8. Epub 2006 Dec 6. Erratum in: Br J Ophthalmol. 2008 Mar;92(3):441-2.

3.

Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.

Luo L, Uehara H, Zhang X, Das SK, Olsen T, Holt D, Simonis JM, Jackman K, Singh N, Miya TR, Huang W, Ahmed F, Bastos-Carvalho A, Le YZ, Mamalis C, Chiodo VA, Hauswirth WW, Baffi J, Lacal PM, Orecchia A, Ferrara N, Gao G, Young-Hee K, Fu Y, Owen L, Albuquerque R, Baehr W, Thomas K, Li DY, Chalam KV, Shibuya M, Grisanti S, Wilson DJ, Ambati J, Ambati BK.

Elife. 2013 Jun 18;2:e00324. doi: 10.7554/eLife.00324.

4.

Sema3A maintains corneal avascularity during development by inhibiting Vegf induced angioblast migration.

McKenna CC, Ojeda AF, Spurlin J 3rd, Kwiatkowski S, Lwigale PY.

Dev Biol. 2014 Jul 15;391(2):241-50. doi: 10.1016/j.ydbio.2014.04.017. Epub 2014 May 6.

5.

Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.

Singh N, Tiem M, Watkins R, Cho YK, Wang Y, Olsen T, Uehara H, Mamalis C, Luo L, Oakey Z, Ambati BK.

Blood. 2013 May 16;121(20):4242-9. doi: 10.1182/blood-2012-08-453043. Epub 2013 Mar 8.

6.

Developmental biology: red-eye redirected.

Marte B.

Nature. 2006 Oct 26;443(7114):928. No abstract available.

PMID:
17066026
8.

Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.

Lai CM, Brankov M, Zaknich T, Lai YK, Shen WY, Constable IJ, Kovesdi I, Rakoczy PE.

Hum Gene Ther. 2001 Jul 1;12(10):1299-310.

PMID:
11440623
9.

Overexpression of Pax6 in mouse cornea directly alters corneal epithelial cells: changes in immune function, vascularization, and differentiation.

Davis J, Piatigorsky J.

Invest Ophthalmol Vis Sci. 2011 Jun 13;52(7):4158-68. doi: 10.1167/iovs.10-6726.

10.

Expression of pro- and anti-angiogenic factors during the formation of the periocular vasculature and development of the avian cornea.

Kwiatkowski S, Munjaal RP, Lee T, Lwigale PY.

Dev Dyn. 2013 Jun;242(6):738-51. doi: 10.1002/dvdy.23956. Epub 2013 Apr 24.

11.
12.

FoxC1-dependent regulation of vascular endothelial growth factor signaling in corneal avascularity.

Koo HY, Kume T.

Trends Cardiovasc Med. 2013 Jan;23(1):1-4. doi: 10.1016/j.tcm.2012.08.002. Epub 2012 Aug 29. Review.

13.

Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.

Ponticelli S, Marasco D, Tarallo V, Albuquerque RJ, Mitola S, Takeda A, Stassen JM, Presta M, Ambati J, Ruvo M, De Falco S.

J Biol Chem. 2008 Dec 5;283(49):34250-9. doi: 10.1074/jbc.M806607200. Epub 2008 Oct 15.

14.

Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.

Malecki M, Trembacz H, Szaniawska B, Przybyszewska M, Janik P.

Oncol Rep. 2005 Dec;14(6):1565-9.

PMID:
16273257
15.

Genetic ablation of CD36 induces age-related corneal neovascularization.

Mwaikambo BR, Sennlaub F, Ong H, Chemtob S, Hardy P.

Cornea. 2008 Oct;27(9):1037-41. doi: 10.1097/ICO.0b013e31817780b6.

PMID:
18812768
16.

Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.

Philipp W, Speicher L, Humpel C.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2514-22.

PMID:
10937562
17.

Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.

Edelman JL, Castro MR, Wen Y.

Invest Ophthalmol Vis Sci. 1999 May;40(6):1112-23.

PMID:
10235544
18.

Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.

Ramachandra S, D'Souza SS, Gururaj AE, Shaila MS, Salimath BP.

J Gene Med. 2009 May;11(5):422-34. doi: 10.1002/jgm.1309.

PMID:
19266483
19.

VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.

Usui T, Ishida S, Yamashiro K, Kaji Y, Poulaki V, Moore J, Moore T, Amano S, Horikawa Y, Dartt D, Golding M, Shima DT, Adamis AP.

Invest Ophthalmol Vis Sci. 2004 Feb;45(2):368-74.

PMID:
14744874
20.

[Expression of vascular endothelial growth factor and its receptors (flt-1) in morbid human corneas and investigation of its clinic importance].

Chen J, Liu W, Liu Z, Chen L, Huang T, Zhen H.

Yan Ke Xue Bao. 2002 Dec;18(4):203-7. Chinese.

PMID:
15515760

Supplemental Content

Support Center